Skip to main content
. 2014 Apr 7;9(4):e93902. doi: 10.1371/journal.pone.0093902

Table 2. Clinical measures before and after 8 weeks of risperidone treatment (N = 80).

Before treatment After treatment t value p value
Weight (Kg) 62.05±10.53 64.06±10.17 −8.90 <0.001
BMI (kg/m2) 22.24±1.86 22.99±1.8 −9.08 <0.001
blood glucose (mmol/l) 4.74±0.45 4.76±0.43 −1.44 0.124
triglyceride (mmol/l) 0.79±0.20 0.81±0.16 −3.11 0.001
cholesterol (mmol/l) 4.45±0.48 4.48±0.43 −3.49 0.001
LDL (mmol/l) 2.07±0.50 2.11±0.47 −1.33 0.189
HDL (mmol/l) 1.27±.015 1.26±0.15 2.05 0.043
PANSS total 71.83±7.18 53.09±8.00 28.47 <0.001
PANSS positive 20.78±4.97 13.71±2.89 13.30 <0.001
PANSS negative 15.00±4.43 10.64±2.12 9.88 <0.001
PANSS general 36.05±8.15 28.90±8.21 10.14 <0.001

BMI: body mass index; PANSS: Positive and Negative SyndromeScale.